Gouty arthropathy: review of clinical manifestations and treatment, with emphasis on imaging

JS Weaver, ER Vina, PL Munk, AS Klauser… - Journal of Clinical …, 2021 - mdpi.com
Gout, a crystalline arthropathy caused by the deposition of monosodium urate crystals in the
articular and periarticular soft tissues, is a frequent cause of painful arthropathy. Imaging has …

Imaging of crystalline arthropathy in 2020

E Filippucci, AM Reginato, RG Thiele - Best Practice & Research Clinical …, 2020 - Elsevier
Crystal-related arthropathies are the result of crystal deposition in joint and periarticular soft
tissues. Identification of urate crystals is mandatory to distinguish gout from other crystalline …

Sonographic estimation of monosodium urate burden predicts the fulfillment of the 2016 remission criteria for gout: a 12-month study

E Cipolletta, J Di Battista, M Di Carlo… - Arthritis Research & …, 2021 - Springer
Objective To investigate whether baseline monosodium urate (MSU) burden estimated by
ultrasound (US) predicts the achievement of the 2016 remission criteria for gout after 12 …

Real-time and accurate calibration detection of gout stones based on terahertz and Raman spectroscopy

H Li, Y Zhou, Y Wu, Y Jiang, H Bao, A Peng… - … in bioengineering and …, 2023 - frontiersin.org
Gout is a metabolic disease that can result in the formation of gout stones. It is essential to
promptly identify and confirm the type of gout stone to alleviate pain and inflammation in …

Predictors of patient and physician assessments of gout control

N Dalbeth, C Frampton, M Fung… - Arthritis Care & …, 2023 - Wiley Online Library
Objective To understand the clinical variables that contribute to the patient and physician
assessments of gout control and which variables predict discordant assessments. Methods …

Profiling of serum oxylipins identifies distinct spectrums and potential biomarkers in young people with very early onset gout

C Wang, J Lu, W Sun, TR Merriman, N Dalbeth… - …, 2023 - academic.oup.com
Objective Oxylipins modulate inflammation via complex pathways. The oxylipin profile in
gout remains unexplored. In this study, we systemically profiled oxylipins in young men and …

Volumetric reduction and dissolution prediction of monosodium urate crystal during urate-lowering therapy–a study using dual-energy computed tomography

CSK Chui, AKY Choi, MMY Lam, TH Kwan… - Modern …, 2021 - academic.oup.com
Objective: Dissolution velocity of monosodium urate (MSU) crystal during urate-lowering
therapy (ULT) had been inadequately studied. By using dual-energy computed tomography …

What is remission in gout and how should we measure it?

N Dalbeth, LK Stamp, WJ Taylor - Rheumatology, 2021 - academic.oup.com
Gout is a chronic disease of monosodium urate crystal deposition that typically presents
initially as an intermittently flaring condition with non-symptomatic inter-critical periods …

Disease modification in gout: a qualitative study of gout expert rheumatologists

JA Singh - Rheumatology Advances in Practice, 2022 - academic.oup.com
Objective The aim was to examine the views of health-care providers regarding disease
modification in gout, with the potential to derive a provisional set of domains for disease …

Gout Remission as a Goal of Urate-Lowering Therapy: A Critical Review

AD Tabi-Amponsah, S Stewart, G Hosie, LK Stamp… - Pharmaceuticals, 2023 - mdpi.com
Urate-lowering therapies for the management of gout lead to a reduction in serum urate
levels, monosodium urate crystal deposition, and the clinical features of gout, including …